• About
  • Careers
  • Newsletter
News Mylan plans generic after backlash

Mylan plans generic after backlash

-

On Aug. 29, pharmaceutical company Mylan announced it would launch a generic epinephrine injection identical in formula to its name-brand Epipen Auto-Injector for less than half the original’s cost.

The price for the anti-allergy medication EpiPen has increased more than 500 percent over a nine-year span.

“If you have an allergy, you get an EpiPen or go to the hospital,” Moffitt Health Center Pharmacy Technician Dana Fordham said. “There is no alternative to EpiPen.”

According to a CNBC report, the EpiPen costs about $15 dollars to make. However, Mylan charges $600 for a two-dose box, and that price might fluctuate depending on where the medication is purchased.

According to Fordham, the Moffitt Health Center buys the two-dose packs at around $500. The product costs students $515 if they do not have insurance.

CVS pharmacist Brent Strickland said there was only one case in the last week in which a person could not afford their medication.

Strickland said most companies get a patent 10 to 20 years before putting a generic product on the market. An authorized generic is a generic product released by a company that owns the name-brand version of that product. Some companies, according to Strickland, use this method to make their products more accessible to consumers unable to afford name-brand products.

To ensure the generic is as effective as the original, companies stay within a 10-percent error margin on bioequivalence.

Strickland said the CVS pharmacy currently pays $317 for a two-pack of EpiPens.

In another recent incident, Turing Pharmaceuticals CEO Martin Shkreli raised the price on Daraprim, according to an ABC report, from $14 to $750.

“We understand the deep frustration and concerns associated with the cost of EpiPen to the patient and have always shared the public’s desire to ensure that this important product be accessible to anyone who needs it,” wrote Mylan CEO Heather Bresch of the EpiPen price hike. “Our decision to launch a generic alternative to EpiPen is an extraordinary commercial response, which required the cooperation of our partner.”

EpiPen remains on most insurances’ authorized drug list at this time.


 

Latest news

The Suffocating Anger George Floyd’s Life Sparked

I wish I wasn’t writing this piece, but was compelled to do so. I’m sick and tired of being a young black man always watching my back out of fear for incidents like this, where George Floyd had a knee on his neck for 8 minutes, as if he was a dog and not human.

Petal Protest May 2020 Photo Gallery

Members of the Petal-Hattiesburg community joined together for three days on the Petal City Hall lawn to...

President announces modifications to Fall Semester

The University of Southern Mississippi (USM) has announced plans to condense the Fall 2020 semester calendar in an effort to limit student travel into and out of the region and help prevent the potential spread of COVID-19.

Media students try to stay positive about post-grad future

Over 1.3 million students across the country prepare for graduation, the biggest challenge they face is finding work in light of the COVID-19 epidemic.

Caution is not enough for students to return

The only way many students will feel comfortable is by rule enforcement to ensure the spread of COVID-19 is put at a halt.

Now is the time to reopen Mississippi

Now is the time to reopen. Our communities will not make it if nonessential businesses remain closed.

Must read

The Suffocating Anger George Floyd’s Life Sparked

I wish I wasn’t writing this piece, but was compelled to do so. I’m sick and tired of being a young black man always watching my back out of fear for incidents like this, where George Floyd had a knee on his neck for 8 minutes, as if he was a dog and not human.

Petal Protest May 2020 Photo Gallery

Members of the Petal-Hattiesburg community joined together...

You might also likeRELATED
Recommended to you